Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Prime Medicine's Pre-Tax Income for the
three
months ended in Mar. 2024 was $-45.63 Mil. Prime Medicine's Revenue for the
three
months ended in Mar. 2024 was $0.59 Mil. Therefore, Prime Medicine's pretax margin for the quarter that ended in Mar. 2024 was -7,720.30%.
The historical rank and industry rank for Prime Medicine's Pretax Margin % or its related term are showing as below:
PRME'
s Pretax Margin % Range Over the Past 10 Years
Min: -34592.22 Med: -29.62 Max: -29.62
Current: -34592.22
PRME's Pretax Margin % is ranked worse than 95.04% of 1028
companies
in the Biotechnology industry
Industry Median: -155.495
vs PRME: -34592.22
Prime Medicine Pretax Margin % Historical Data
The historical data trend for Prime Medicine's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Prime Medicine's Pretax Margin %
For the Biotechnology subindustry, Prime Medicine's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prime Medicine's Pretax Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Prime Medicine's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Prime Medicine's Pretax Margin % falls into.
Prime Medicine Pretax Margin % Calculation
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
Prime Medicine's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prime Medicine (NAS:PRME) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Prime Medicine Pretax Margin % Related Terms
Thank you for viewing the detailed overview of Prime Medicine's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Prime Medicine (Prime Medicine) Business Description
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRME has been successfully added to your 